Answer
Hepatic impairment may increase ciclosporin exposure approximately 2- to 3-fold; severe liver impairment may require dose reduction to maintain recommended target blood levels, with blood-level monitoring recommended until stable levels are reached.
Sources for this answer
- Neoral Soft Gelatin CapsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 36Document updated
Sources checked